Researchers evaluated whether cognitive decline and dementia are compressed among individuals with longer lifespans.

A new companion to the GSA KAER Toolkit for Brain Health helps clinicians and caregivers promote brain health, detect cognitive changes early, and support adults with intellectual and developmental disabilities.

Researchers assessed why living in a disadvantaged neighborhood may be linked to an increase in an individual’s risk for dementia.

Researchers examined whether exposure to common infectious agents was associated with cognitive performance and risk for mild cognitive impairment or dementia in older adults.

Researchers examined survival and all-cause mortality rates in early-onset dementia from January 2010 to December 2021.

Educating nurses about the 4AT screening tool can help staff effectively manage delirium, according to research results presented at GAPNA 2025.

Researchers examined the association between physical inactivity and progression of Alzheimer disease pathology in humans using step counts in cognitively unimpaired older adults.

Researchers examined how Life’s Essential 8 and genetic risk for dementia affect the risk for MCI and dementia in a study of 15,613 participants with diabetes.

Researchers conducted a 2-arm, blinded randomized controlled trial involving adults receiving mechanical ventilation in ICUs to examine the impact of the FAVoR intervention vs usual care.

Researchers determined whether initial clinical data could accurately distinguish Alzheimer disease from behavioral variant frontotemporal dementia using machine learning models validated by autopsy findings.

The Dementia Friends sessions focus on 5 key messages that debunk myths about dementia and improve outpatient clinic staff’s knowledge of the condition.

Researchers compared the efficacy of pharmacologic, nonpharmacologic, and combined treatments for older adults with mild to moderate Alzheimer Disease.

Investigators evaluated community-acquired pneumonia mortality rates among patients with and without dementia.

Agitation is the third most common neuropsychiatric symptom observed in patients with dementia, with 30% of patients exhibiting these symptoms; the frequency increases to 80% among patients living in nursing facilities.

Researchers conducted a trial involving 47 participants with mild cognitive impairment or early Alzheimer disease or who were amyloid-positive.

Researchers examined the health profiles of older adults with diagnosed with both diabetes and Alzheimer disease.

Researchers examined associations of the area deprivation index, social vulnerability index, and environmental justice index with biomarkers of Alzheimer disease and related dementias.

Researchers estimated the association between inpatient physician prescribing of first-generation antihistamines and delirium among older general medicine inpatients.

Researchers examined the association between a cancer diagnosis and the subsequent development of dementia.

Researchers evaluated comorbidity trends in the mild cognitive impairment subtypes and how race plays a role in those relationships.

Researchers conducted a cohort study to assess the relationship between type 1 diabetes and dementia risk.

Researchers examined whether prior zoster vaccination reduces major adverse cardiovascular events, dementia, and all-cause mortality among older adults with HZ in a retrospective matched cohort study.

Researchers examined the association between incident benzodiazepine or antipsychotic use and 180-day mortality among nursing home residents with ADRD enrolled in hospice.

Researchers examined whether long-term cognitive trajectories improved following mid- to late-life smoking cessation.

Researchers evaluated whether plasma phosphorylated tau 217 could reliably classify amyloid β status in cognitively unimpaired individuals.

Researchers assessed cognitive function following COVID-19 infection among middle-aged individuals.

Researchers assessed how a lower vs higher oxygenation target affected cognitive and pulmonary function in ICU patients with acute hypoxemic respiratory failure.

Researchers examined whether reduced kidney function affected the predictive accuracy of plasma biomarkers for cognitive decline and neuroimaging outcomes.

The blood-based biomarker test measures Tau protein phosphorylated at threonine 181 in human plasma (pTau181).

Researchers examined how low-level blast exposure relates to cognitive functioning in military personnel, including how it interacts with PTSD and mild traumatic brain injury.